miltefosine has been researched along with ciprofloxacin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Akhtar, W; Akhter, M; Alam, MM; Khan, MF; Nainwal, LM; Parvez, S; Shaquiquzzaman, M; Tasneem, S; Verma, G | 1 |
| Branco, LC; Costa, A; Duarte, CM; Florindo, C; Marrucho, IM; Matias, AN; Matos, C; Nunes, SL; Rebelo, LP | 1 |
1 review(s) available for miltefosine and ciprofloxacin
| Article | Year |
|---|---|
Green recipes to quinoline: A review.
Topics: Drug Design; Green Chemistry Technology; Humans; Quinolines | 2019 |
2 other study(ies) available for miltefosine and ciprofloxacin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Novel organic salts based on fluoroquinolone drugs: synthesis, bioavailability and toxicological profiles.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Biological Availability; Caco-2 Cells; Cell Survival; Chemistry, Pharmaceutical; Ciprofloxacin; Gluconates; Glycolates; Humans; Intestinal Absorption; Intestinal Mucosa; Mesylates; Micelles; Norfloxacin; Phosphorylcholine; Solubility; Solvents; Technology, Pharmaceutical; Water | 2014 |